Inhibitory effects of silymarin on hepatic fibrosis induced by dimethylnitrosamine: Experiment with rats

National Medical Journal of China

Volumn 86, Issue 36, 2006, Pages 2563-2566

  Zhao, Xin Yan ^a   Wang, Bao En ^b   Wang, Tai Ling ^b   Li, Xi Min ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

Dimethylnitrosamine; Liver cirrhosis; Silymarin

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; DIMETHYLNITROSAMINE; HYDROXYPROLINE; SILYMARIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFICACY; EXPERIMENTAL MODEL; FEEDING; HISTOPATHOLOGY; LIVER FIBROSIS; MALE; MICROSCOPY; NONHUMAN; RANDOMIZATION; RAT; RAT STRAIN; STOMACH;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; DIMETHYLNITROSAMINE; HYDROXYPROLINE; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; LIVER FUNCTION TESTS; MALE; PROTECTIVE AGENTS; RANDOM ALLOCATION; RATS; RATS, WISTAR; SERUM ALBUMIN; SILYMARIN;

EID: 33751406022     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Chinese source. 2005,85:1219-1221.
2. Saller R, Meier H, Brignoli R. The use of silymarin in the treatment of liver diseases. Drugs,2001,61:2035-2063.
3. Mayer KE, Myers RP, Lee SS. Silymarin treatment of viral hepatitis: a systematic review. J Viral Hepat,2005,12:559-567.
4. Mourelle M, Muriel P, Farvari L, et al. Prevention of CCL4-induced liver cirrhosis by silymarin. Fundam Clin Pharmacol, 1989, 3: 183-191.
5. Boigk G, Stroedter L, Herbst H, et al. Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats. Hepatology, 1997, 26: 643-649.
6. Chong LW, Hsu YC, Chiu YT, et al. Anti-fibrotic effects of thalidomide on hepatic stellate cells and dimethylnitrosamine-intoxicated rats. J Biomed Sci,2006,13:403-418.
7. Hsu YC, Lin YL, Chiu YT, et al. Antifibrotic effects of Salvia miltiorrhiza on dimethylnitrosamine- intoxicated rats. J Biomed Sci, 2005,12:185-195.
8. Yen MH, Weng TC, Liu SY, et al. The hepatprotective effects of Bumpleurum kaoi, an endemic plant to Taiwan, against dimenthylnatrothemine-induced hepatic fibrosis in rats. Biol Pharm Bull, 2005,28:442-448.
9. Lieber CS, Leo MA, Cao Q, et al. Silymarin retards the progression of alcohol-induced hepatic fibrosis in baboons. J Clin Gastroenterol, 2003,37:336-339.
10. Chinese source. 2000,27:295-298.
11. Scheuer PJ. Scoring of liver biopsies: are we doing it right? Eur J Gastroenterol Hepatol,1996,8:1141-1143.
12. Chinese source. 1994,14:333-335.
13. Lee HS, Huang GT, Miau LH, et al. Expression of matrix metalloproteinases in spontaneous regression of liver fibrosis. Hepatogastroenterology,2001,48:1114-1117.
14. Chinese source. 2005,85:1009-1010.
15. Jeong DH, Lee GP, Jeong WI, et al. Alterations of mast cells and TGR-beta1 on the silymarin treatment for CCL4-induced hepatic fibrosis. World J Gastroenteral,2005,11:1141-1148.
16. Jia JD, Bauer M, Cho JJ, et al. Antifibrotic effect of silymarin in rat secondary biliary fibrosis is mediated by downregulation of procollangen alphal (1) and TIMP-1. J Hepatol,2001,35:392-398.